_introduction-to-public-administration-preview-1.jpg "INTRODUCTION TO PUBLIC ADMINISTRATION from public administration syllabus pdf Video Screenshot Preview 1")
Gallery_introduction-to-public-administration-preview-3.jpg "INTRODUCTION TO PUBLIC ADMINISTRATION from public administration syllabus pdf Video Screenshot Preview 3")
Gallery_introduction-to-public-administration-preview-hqdefault.jpg "INTRODUCTION TO PUBLIC ADMINISTRATION from public administration syllabus pdf Video Screenshot Preview hqdefault")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Jump To Video Parts
⏲ Duration: 3 minutes 9 seconds
👁 View: 7K times
Play Audio:👁 View: 7K times
Description:
Aisya Academy
Aisya Academy
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_srushti-jayant-deshmukh-shares-her-upsc-booklist-and-resources-124-lbsnaa-the-burning-desire.webp "LBSNAA The Burning Desire")
⏲ 3 minutes 32 seconds 👁 1.2M
_best-optional-for-upsc-by-vikash-divyakirti-sir-drishti-ias-upsc-guidance-for.webp "Lbsnaa Wale")
⏲ 9 minutes 👁 482.4K
_tesla-announces-recall-for-cybertruck-due-to-acceleration-issue.webp "Welcome to Fan Reviews News. Tesla is issuing a recall due to an acceleration defect found in the Cybertruck. This defect can potentially cause unintentional vehicle acceleration, increasing the risk of a crash. Elon Musk's electric vehicle and clean energy company, Tesla, recently notified the National Highway Traffic Safety Administration of this issue. According to the notice, the accelerator pedal on the Cybertruck may become trapped, affecting its performance and operation. This poses a potential risk for collisions. It's important to note that Tesla is not aware of any collisions or injuries related to this defect. Rest assured, Tesla is taking immediate action to address the issue. We will keep you updated as this story develops, on Fan Reviews News.")
_public-administration-124124-kerala-psc-exam-syllabus-based-class.webp "chakrapani classes 2.0")
⏲ 44 minutes 42 seconds 👁 38.4K
_plans-revealed-to-give-millions-across-britain-access-to-new-rail-routes.webp "Millions of people across Britain will have access to new train services under rail industry plans. Open access services on seven routes are being developed in a bid to boost connectivity, increase competition and reduce fares, analysis by the PA news agency found.")
_the-evolution-of-public-administration.webp "GreggU")
_how-to-increase-p1-score-in-public-administration-jrf-p1-varsha-mam-jrfadda.webp "JRFAdda")
⏲ 11 minutes 41 seconds 👁 114
_latest-weight-loss-drug-faces-shortages.webp "Latest Weight-Loss Drug , Faces Shortages .<br/>The United States Food and Drug Administration <br/>(FDA) says that high demand has left the latest <br/>weight-loss drug, Zepbound, in short supply.<br/>'Newsweek' reports that the Eli Lilly product<br/>is expected to experience limited availability <br/>through Q2 of 2024 as surging demand has <br/>outpaced the manufacturer's expectations.<br/>We have experienced <br/>an unparalleled surge in <br/>demand for our type 2 <br/>diabetes and obesity medicines, Eli Lilly spokesperson, via 'Newsweek'.<br/>We recognize this situation may <br/>cause a disruption in peoples' <br/>treatment regimens and are <br/>working with purpose and <br/>urgency to help meet <br/>the surge in demand, Eli Lilly spokesperson, via 'Newsweek'.<br/>The FDA said that Novo Nordisk's weight-loss <br/>drug, Wegovy, is also experiencing a <br/>widespread supply shortage with no end <br/>in sight for the drug's limited availability.<br/>By the year 2030, 'Newsweek' reports <br/>that the weight-loss drug market is <br/>expected to grow to about $100 billion.<br/>We expect our investments <br/>in manufacturing and supply <br/>capacity to progressively increase <br/>production of our medicines <br/>throughout 2024 and beyond, Eli Lilly spokesperson, via 'Newsweek'.<br/>Over the past year, manufacturer Eli Lilly <br/>has already seen share prices rise over 102%.<br/>The company has announced plans <br/>to expand operations to meet increased <br/>demand for its incretin products which are <br/>used in the firm's diabetes treatments. .<br/>Incretin mimics gut hormones <br/>that regulate blood sugar <br/>while also suppressing appetite")
_srushti-jayant-deshmukh-shares-her-upsc-booklist-and-resources-124-lbsnaa-the-burning-desire.jpg)
_best-optional-for-upsc-by-vikash-divyakirti-sir-drishti-ias-upsc-guidance-for.jpg)
_tesla-announces-recall-for-cybertruck-due-to-acceleration-issue.jpg)
_public-administration-124124-kerala-psc-exam-syllabus-based-class.jpg)
_plans-revealed-to-give-millions-across-britain-access-to-new-rail-routes.jpg)
_the-evolution-of-public-administration.jpg)
_how-to-increase-p1-score-in-public-administration-jrf-p1-varsha-mam-jrfadda.jpg)
_latest-weight-loss-drug-faces-shortages.jpg)
![[+]](/images/menu.gif){kind=small}